- About Us
- Leadership
Leadership
Add a header to begin generating the table of contents
Executive Leadership Team
Surya Singh, M.D.
CEO
Dr. Surya Singh is a seasoned healthcare executive with leadership experience across large public and private corporations, small entrepreneurial companies, and nonprofits. A longtime architect and supporter of payor sponsored value-based care initiatives, he is passionate about driving better patient outcomes through the adoption of precision medicine.
Dr. Singh has served as a senior advisor to several organizations active in designing and implementing value-based reimbursement programs, with a particular focus on the use of genetics, genomics, and complex, high-cost therapies.
Previously, Surya was CEO and Co-Founder of gWell, Corporate Vice President and Chief Medical Officer at CVS Health Specialty, Chief Medical Officer of Emerging Therapy Solutions, Chief Medical Officer and Head of Product at Proventys, (acquired by McKesson Corporation); Chief Medical Officer and SVP of Clinical Operations at D2Hawkeye (now part of Verisk Health); Healthcare Strategy Consultant at McKinsey and Company; and attending physician/hospitalist at Brigham & Women’s Hospital.
Surya is licensed and board certified in internal medicine and is an Adjunct Instructor of Medicine at Harvard Medical School. He lives in Lexington, Massachusetts with his wife (a practicing gastroenterologist) and their three sons.
David Patrick Nixon
Co-Founder and Executive Chairman
David brings 25 years of healthcare experience and a record of entrepreneurial leadership to his role as executive chairman. Having joined InformedDNA in 2007 as CEO, David led the company’s transformation from the first national telehealth genetic counseling services provider to becoming the first mover in the now rapidly growing fields of genetic testing utilization management and applied genomics solutions. To fuel the company’s growth, David orchestrated three rounds of venture capital funding and, in 2019, a majority recapitalization. He was previously founder/CEO of The Nixon Group, a marketing communications firm acquired by Interpublic Group [NYSE: IPG] in 2002. David serves on the boards of Foundation Fighting Blindness, American Council on Exercise (ACE), and Florida Venture Education Foundation, and is director emeritus for Facing Our Risk of Cancer Empowered (FORCE). The through-line for his career has been ensuring that people have access to accurate expert information to make their own well-informed decisions, which he continues at InformedDNA.
Rebecca Sutphen, MD, FACMGG
Co-Founder and Chief Medical Officer
Dr. Rebecca Sutphen has extensive clinical and molecular genetics expertise, having previously served for more than a decade as Director of Clinical Genetics for Moffitt Cancer Center and for Johns Hopkins All Children’s Hospital. She is among the few individuals to attain certification by the American Board of Medical Genetics and Genomics in Clinical Genetics, Molecular Genetics and Cytogenetics and is also an experienced NIH-funded researcher with more than 50 peer-reviewed publications.
Megan Czarniecki, MS, MA, CGC
Chief Operating Officer
Megan Czarniecki oversees all of InformedDNA’s clinical genetics operations and has been with the company for nearly a decade. She carries deep subject matter expertise in genomics, utilization management, telehealth, and medical policy. Prior to joining InformedDNA, Megan practiced as a clinical genetic counselor specializing in reproductive and neonatal genetics, newborn screening and medical ethics. Megan earned a Bachelor of Arts degree in Anthropology and French from Grinnell College, followed by dual Master’s degrees in Genetic Counseling and Medical Humanities & Bioethics from Northwestern University.
Sobha Pisharody, PhD
Chief Strategy & Product Officer
Dr. Sobha Pisharody leads InformedDNA’s product strategy and development initiatives. Prior to joining InformedDNA, she founded and grew a consulting practice leveraging more than 20 years of experience to helping product companies identify opportunities and design products to ensure strong market growth. She has held senior leadership roles in both startups and large companies, from chief product officer at Hound Labs to senior vice president of product and strategy at Talis Biomedical, and director of product management at Thermo Fisher Scientific, where she led businesses within the qPCR and Capillary Electrophoresis franchises. Prior to that, Sobha was the founder and CEO of GenoRx, Inc., a molecular diagnostic startup. She holds a Ph.D. in molecular oncology and immunology from the New York University School of Medicine and a B.S. in genetics from the University of California at Berkeley.
Donogh O’Driscoll
Chief Financial Officer
As CFO, Donogh oversees InformedDNA’s finance and accounting functions, playing a significant role in strategic leadership. He has worked in the scientific and healthcare space for more than 15 years, building and leading finance teams and most recently served as VP and GM for publicly traded Hologic Inc. Prior to Hologic, Donogh held various positions of increasing responsibility and has served on multiple boards domestically and internationally. He began his career with KPMG and is a fellow of the Institute of Chartered Accountants; he also holds a Bachelor of Business Studies. Donogh brings deep experience not only in healthcare but in M&A activity; his experience and expertise will further enable InformedDNA’s mission.
Doug Berman
Senior Vice President, Channel & Account Management
As SVP of Channel & Account Management, Doug is dedicated to delivering exceptional outcomes and experiences to InformedDNA clients. He has spent more than 20 years in the healthcare industry, partnering with senior executives of major health plans, health systems, and employers on adopting emerging technologies for improving clinical, operational, and financial performance. Doug’s client success leadership helped drive the growth of several early-stage companies in the virtual care and data analytics space. He also oversaw client M&A activities for Advanced Practice Strategies and Verisk Health. Doug earned a BA from Denison University and an MBA from Boston University.
Joe Ruvalcaba
Chief Technology Officer
Joe Ruvalcaba brings more than 20 years of experience in systems engineering, business architecture, and technology strategy to InformedDNA. An innovative and dynamic tech executive with 10 years of healthcare experience, Joe leads InformedDNA’s technology initiatives. Prior to joining InformedDNA, he was the Vice President of Architecture at AbleTo, a company pioneering high-quality virtual behavioral health care. As CTO at InformedDNA, Joe partners closely with our Product organization to design solutions that enhance product value and solve our customer’s real-world business challenges.
Clinical Leadership Team
Gwen Fraley, MS, CGC
VP, Clinical Research & Design
Denise Jones, MS, CGC
VP, Clinical Operations
Erin Engel, MS, CGC
VP, Product
Kim Schahl, MS, CGC
Director, Genomic Applications
Whitney Ducaine, MGC, CGC, CN-BM
Director, Cancer Genetics Services
Marie Schuetzle, MS, CGC
Director, Reproductive & Ocular Clinical Services
Tricia See, ScM, CGC
Director, Cardiac & Neurogenetics Clinical Services
Rebecca Sutphen, MD, FACMGG
Co-Founder and Chief Medical Officer
- Collaborative Professor, University of South Florida Morsani College of Medicine
- Former Director of Clinical Genetics at Moffitt Cancer Center & Research Institute
- Researcher funded by the American Cancer Society, the Department of Defense, National Institutes of Health and Patient-Centered Outcomes Research Institute
- Attained certification by the American Board of Medical Genetics in clinical genetics, molecular genetics and cytogenetics – one of the few physicians to hold this distinction
- Attained board certification in pediatrics
- Served for more than a decade as the Director of Clinical Genetics for the only NCI-designated Comprehensive Cancer Center in Florida, the Moffitt Cancer Center, as well as Director of Clinical Genetics for the large university-affiliated tertiary children’s hospital, All Children’s Hospital, that is now part of the Johns Hopkins Healthcare System
- Served for 12 years on the NCCN guidelines committee that sets the standard for clinical genetic testing
- Served as an invited expert member of Medicare’s Advisory Committee on Clinical Diagnostic Laboratory Testing and the CMS subcommittee on Advanced Diagnostic Laboratory Testing
Gwen Fraley, MS, CGC
Director, Clinical Strategy
- Board-certified Genetic Counselor since 2005
- MS in Genetic Counseling Mount Sinai School of Medicine
- BA in Biology from the University of Oregon
- Member of the National Society of Genetic Counselors
- Former genetic counselor at Oregon Health and Sciences University; Evanston Hospital Fetal Diagnostic Center; Perinatal Center at Doernbecher Children’s Hospital; Mount Sinai Medical Center; Southwest Washington Medical Center; and Salem Hospital
- Former instructor of Clinical Obstetrics and Gynecology at Feinberg School of Medicine, Northwestern University
- Former guest lecturer of the Graduate Program in Genetic Counseling at Northwestern University
- Presented research at Annual Pacific Northwest Update in OB-GYN and Women’s Health; Annual Education Conference of the National Society of Genetic Counselors; and the American Society of Human Genetics Annual Meeting
- Research published in the Journal of Maternal Fetal Neonatal Medicine
"I loved clinic and my experience caring for patients. Now I get to use what I learned in that setting to address access to genetic services from a public health perspective."
Megan Czarniecki, MS, MA, CGC
Chief Operations Officer
- Board-certified Genetic Counselor since 2009
- M.S. in Genetic Counseling from Northwestern University
- M.A. in Bioethics and Medical Humanities from Northwestern University
- B.A. in Anthropology and French from Grinnell College
- Former clinical genetic counselor specializing in reproductive genetics and newborn screening
- Former Research Technician at Northwestern University Feinberg School of Medicine
- Member of National Society of Genetic Counselors
- Research published in Genetics in Medicine.
- Presented research at the American College of Medical Genetics Annual Meeting and National Society of Genetic Counselors Annual Meeting
“I have always been drawn to the intersection between science and psychology, and genetic counseling marries the two perfectly.”
Kelly Athman, MS, CGC
Senior Director, Medical Affairs
- Board-certified Genetic Counselor since 2010
- M.S. in Molecular, Cellular, Developmental Biology & Genetics and a B.A. in Psychology and Biology from the University of Minnesota
- More than 15 years of experience in the healthcare industry
- Former Director, Utilization Management at InformedDNA
- Former genetic counselor for Fairview Hospitals and Clinics, Children’s Mercy Hospital, and CentraCare Health Systems
- Former member of the National Society of Genetic Counselors Leadership Development Task Force
- Presentations at the National Society of Genetic Counselors Annual Education Conference and the Minnesota Genetic Counselor Association Annual Education Conference
- Research published in Neuropsychopharmacology
"Prior to pursuing a career in genetic counseling, I worked within a health plan discussing benefits with members. This experience and my time as a clinical genetic counselor fuel my passion to ensure access to high-quality genomics care and appropriate genetic testing."
Kim Schahl, MS, CGC
Director, Genomic Applications
- Board-certified Genetic Counselor since 2002
- M.S. in Genetic Counseling from Northwestern University
- B.A. in Biology from Augustana College
- Diplomate of the American Board of Genetic Counseling
- Member of the National Society of Genetic Counseling
- Former genetic counselor at the Mayo Clinic Center for Individualized Medicine and Molecular Genetics Laboratory
- Former genetic counselor at the University of Chicago College of Medicine, in the Department of Pediatrics
- Former instructor in Laboratory Medicine and Pathology at the Mayo Clinic College of Medicine
- Developed general genetics curriculum at the University of Illinois at Chicago, College of Medicine
- Developed the genetic counseling laboratory internship course at Mayo Clinic College of Medicine
- Guest lecturer and presenter at St. Francis Medical Center; Illinois Central College; Proctor Hospital; Illinois Department of Public Health; Mayo Medical School; Northwestern University; and Rochester Community and Technical College
- Research published in the Illinois Teratogen Information Service; Laboratory Investigation; Communiqué; PLOS Genetics; American Journal of Medical Genetics; Mayo Clinic Proceedings; and Breast Cancer Research and Treatment.
“Clinical genetics has always interested me, but my time as a laboratory genetic counselor really sparked my nerdy love of molecular genetics.”
Erin Engel, MS, CGC
Senior Director, Product Management
- Board-certified Genetic Counselor since 2012
- M.S. in Genetic Counseling from the University of Minnesota, Twin Cities
- B.A. in Genetics, Cell Biology & Development with a Minor in Psychology from the University of Minnesota, Twin Cities
- Certified Associate in Project Management (CAPM), Project Management Institute
- Certified Professional Project Manager (CPPM), University of St. Thomas
- Certified Agile Practitioner (UST-CAP), University of St. Thomas
- Former genetic counselor at the Virginia Piper Cancer Institute Cancer Clinic, Abbott Northwestern Hospital
- Member of the National Society of Genetic Counselors, including former member of the NSGC CEU Review Team
- Member of the Minnesota Genetic Counselors Association
- Former coordinator of the Minnesota Genetic Counseling Experience Program
- Former clinical supervisor for students from the University of Minnesota Genetic Counseling Program
"I've had a fascination with genetics and a passion for spreading science education since high school. I feel so fortunate to have found the field of genetic counseling which marries my intellectual and personal interests and allowed me to find a professional role where I have the opportunity to expand access to genetics expertise across the country!"
Whitney Ducaine, MGC, CGC, CN-BM
Director, Cancer Genetics Services
- Board-certified Genetic Counselor since 2005
- Certified Breast Patient Navigator in Breast Management since 2013
- Master’s in Genetic Counseling from the University of Maryland School of Medicine
- B.S. in Biology from the University of Georgia
- Former genetic counselor at William Beaumont Hospital – Beaumont Cancer Genetics Program; Magee-Women’s Hospital
- Former research specialist at Emory University Department of Urology
- Member of the National Society of Genetic Counselors
- Assisted in the identification of DNA of victims from Hurricane Katrina
- Research published in the Journal of Genetic Counseling, Connecticut Medicine and BioTechniques
- Research presented at National Consortium of Breast Centers Annual Education Conference; Michigan Cancer Consortium Annual Education Conference; National Society of Genetic Counselors Annual Education Conference; Collaborative Group of the Americas on Hereditary Colorectal Cancer Annual Meeting; Annual Beaumont DNA Symposium; American Society of Clinical Oncology Annual Meeting; and National Consortium of Breast Centers Annual Conference.
“I was always interested in a healthcare field that helped people. That ability to partner with patients in order to help them understand their risk and what they can do to improve their health makes me love being a genetic counselor."
Marie Schuetzle, MS, CGC
Director, Reproductive & Ocular Clinical Services
- Board-certified Genetic Counselor since 2005
- M.S. in Genetic Counseling from Indiana University
- B.A. in Biology from the College of Saint Benedict
- Former genetic counselor at Mayo Clinic’s Molecular Genetics Laboratory, Maternal Fetal Medicine, Obstetrics and Gynecology and Reproductive Endocrinology Departments and Indiana University Department of Obstetrics and Gynecology
- Former Laboratory Technician at Washington University Department of Molecular Genetics
- Member of the National Society of Genetic Counseling</span
- Previous Mayo Clinic Reproductive Medical Advisory Board Member and Instructor in Laboratory Medicine and Pathology
- Research presented at American College of Medical Genetics Annual Conference; American Society of Reproductive Medicine Annual Meeting; Society of Maternal Fetal Medicine Annual Meeting
- Guest lecturer at National Society of Genetic Counselors, Mayo School of Continuing Medical Education, Mayo Medical School, Mayo Clinic Department of Obstetrics & Gynecology, Mayo School of Health Sciences, American Society for Clinical Laboratory Science, North Dakota Cancer Coalition Annual Conference, University of North Dakota School of Medicine and Health Services, University of Mary and Saint John’s University
- Research published in Diseases and Disorders, and Prenatal Diagnosis
“I have always loved science and sharing information - I even missed a high school prom to present at a science fair. Being a genetic counselor allows me to support families' understanding and use of genetic information in a way that is meaningful to their health.”
Shanna Gustafson, MPH, MS, CGC
Senior Client Executive
- Board-certified Genetic Counselor since 2007
- MS in Genetic Counseling from The University of Pittsburgh School of Public Health
- MPH with a focus in Genetics from The University of Pittsburgh School of Public Health
- BS in Genetics and Cellular Development from the University of Minnesota
- Former genetic counselor at Cleveland Clinic Health System; Former genetic counselor at William Beaumont Hospital; Former genetic counselor at University of Michigan Health System; Former graduate student researcher at the Children’s Hospital of Pittsburgh
- Member of the National Society of Genetic Counselors
- Member of National Society of Genetic Counselors, including former leadership roles in Access and Service Delivery and Public Policy Committees
- Research published in the Journal of Clinical Oncology; Journal of Genetic Counseling; Genetics in Medicine; Gastrointestinal Cancer Research; Seminars in Oncology; JAMA Dermatology; and Familial Cancer
- Presentations at National Society of Genetic Counselors annual education meetings, Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting, World Research Group Medical Policy and Molecular Diagnostics/Genetic testing Forum, American Society of Human Genetics Annual Meeting, and the Sickle Cell Disease Associations annual convention.
"I decided I wanted to be a genetic counselor when I was in high school, it was only after working as a clinical genetic counselor for a few years that I found I was most passionate about the many ways we can improve access to appropriate genetic care for patients and I have been pursuing opportunities that provide these experiences ever since."
Tricia See, ScM, CGC
Director, Cardiac & Neurogenetics Clinical Services
- Board-certified Genetic Counselor since 2005
- Sc.M. in Genetic Counseling from Johns Hopkins University
- B.A. in Genetics from Cornell University
- Former genetic counselor at Children’s Hospital Boston; University of California San Francisco Memory and Aging Center; Children’s National Medical Center, Center for Prenatal Evaluation
- Guest lecturer at Children’s National Medical Center and University of California San Francisco
- Full member of the National Society of Genetic Counselors
- Research published in Acta Neuropathologica Communications; Journal of Geriatric Psychiatry and Neurology; Handbook of Genomics and the Family; and Neurology Journal of the American Medical Association
“I knew I wanted to be a genetic counselor since my high school AP biology class. I have loved the field of genetic counseling ever since then!”
Denise Jones, MS, CGC
Director, Utilization Management
- Board-certified Genetic Counselor since 2009
- M.S. in Medical Genetics from The University of Wisconsin-Madison
- B.S. in Biology and with a minor in Psychology and Biotechnology from The University of Wisconsin-Platteville
- Former cancer genetic counselor for Virginia Piper Cancer Institute, Minneapolis, MN
- Member of National Society of Genetic Counselors
- Member of Minnesota Genetic Counselors Association, including former vice chair and cancer club chair
- Former clinical supervisor for students from the University of Minnesota Genetic Counseling Program
"Genetics has always fascinated me and now I have the opportunity to delve into it everyday along with educating others. It is truly an exciting time to be a genetic counselor!"
Board of Directors
David brings 25 years of healthcare experience and a record of entrepreneurial leadership to his role as executive chairman. Having joined InformedDNA in 2007 as CEO, David led the company’s transformation from the first national telehealth genetic counseling services provider to becoming the first mover in the now rapidly growing fields of genetic testing utilization management and applied genomics solutions. To fuel the company’s growth, David orchestrated three rounds of venture capital funding and, in 2019, a majority recapitalization. He was previously founder/CEO of The Nixon Group, a marketing communications firm acquired by Interpublic Group [NYSE: IPG] in 2002. David serves on the boards of Foundation Fighting Blindness, American Council on Exercise (ACE), and Florida Venture Education Foundation, and is director emeritus for Facing Our Risk of Cancer Empowered (FORCE). The through-line for his career has been ensuring that people have access to accurate expert information to make their own well-informed decisions, which he continues at InformedDNA.
Dan Lieber brings more than 25 years of leadership experience driving innovation and growth for healthcare and other industry organizations. He joined InformedDNA after being the president and COO of AbleTo, a technology-enabled provider of quality behavioral health solutions, where he contributed to the significant growth and successful sale of the company to Optum in 2020. In prior positions, he has led efforts to deliver better quality services to consumers while achieving superior financial results. Dan brings broad-based healthcare experience and perspective to support InformedDNA’s mission to leverage genomic insights to cost-effectively achieve improved clinical outcomes.
Dr. Rebecca Sutphen has broad clinical and molecular genetics expertise in conditions affecting both adults and children. She is among the few individuals certified by the American Board of Medical Genetics in clinical genetics, molecular genetics and cytogenetics. Rebecca previously served as director of Clinical Genetics for Moffitt Cancer Center & Research Institute. She is also an experienced researcher in genomics and proteomics and has been funded by the American Cancer Society, the Department of Defense, and the National Institutes of Health. Rebecca has received numerous awards and honors, including being named to “Florida’s Super Doctors,” “America’s Top Doctors for Cancer,” and “Best Doctors in America,” as well as the National Comprehensive Cancer Network Guidelines Panel, which sets the standard-of-care for genetics and familial cancer screening.
Vern Davenport is a partner at NovaQuest Capital Management with extensive executive experience in building and transforming healthcare technology and services companies. He is responsible for transaction origination and execution, portfolio company value creation initiatives, and investment policy. Before joining NovaQuest Capital, Vern was CEO and board member at Medfusion. He was instrumental in the carve-out of the company from Intuit and returning its core portal solution to a market leadership position. Prior to Medfusion, Vern was chairman and CEO of Medquist, a leader in transcription services before and after the privatization of the company. There, he facilitated a transformation of the business through the acquisition of a speech technology company, rebranding the company M*Modal and leading the take-private process. Vern’s previous experience also includes his time as president, Allscripts; CEO, Misys Healthcare; GM & EVP, Kodak Health Group (now Carestream Health); and, executive leadership roles at Siemens and Shared Medical Systems. He started his career at IBM where he spent 11 years in sales, sales leadership, and executive management positions. Vern holds a B.S.B.A and an M.B.A from East Carolina University, and is on the East Carolina Board of Trustees and WakeMed Health and Hospitals Board.
Conor Green is a principal at TT Capital Partners (TTCP) and works on sourcing and leading investments in healthcare services and healthcare information technology companies. During his career he has evaluated and worked with many different businesses, as an operator, advisor, and an investor. At TTCP, he works closely with a number of portfolio companies to help maximize their potential. Prior to joining TripleTree, Conor served in a product strategy role at athenahealth, a publicly-traded provider of web-based software and services to physicians. Prior to that, he worked in M&A and strategy roles within Reed Elsevier, but primarily with Elsevier, the company’s science publishing division. Conor began his career at L.E.K. Consulting, where he completed engagements in the M&A due diligence practice as well as a number of longer-term projects for healthcare IT and life sciences clients. Conor earned a B.A. in Politics from Princeton University and an M.B.A. from the Stanford Graduate School of Business.
Michael Sorensen is a partner at NovaQuest Capital Management with extensive investment experience. He is responsible for transaction origination and execution, portfolio company value creation initiatives, investment policy, and investor relations. He is also member of the Private Equity investment committee. Prior to NovaQuest Capital, Michael was a director in BlackRock’s private equity group. In that role, he was responsible for making investment decisions in a wide variety of geographies and industries, including healthcare, technology, and consumer/retail, among others. Prior to BlackRock, Michael worked at Sorenson Capital (no familial relation), a mid-market private equity firm based in Salt Lake City. Similar to his current role, he analyzed private companies in a wide range of industry sub-sectors and geographies. Michael also worked as a consultant for L.E.K. Consulting, where he worked closely with clients’ senior management on projects that included asset optimization, strategic planning, and customer segmentation, primarily in the healthcare and media industries. Michael holds a B.S. in Economics from Brigham Young University, an M.P.A. from Harvard University, and an M.B.A. from the Wharton School at the University of Pennsylvania.
Dr. Jacqueline (Jackie) Kosecoff works in private equity to identify, select, mentor and manage health services and IT companies. She is managing partner at Moriah Partners, LLC, and senior advisor at Warburg Pincus. Previously, she served as a senior executive with UnitedHealth Group-PacifiCare where she was chief executive officer of OptumRx. Jackie was founder, president and chief operating officer of Protocare, and earlier, served as professor of Medicine and Public Health at the University of California, Los Angeles. She holds a B.A. from the University of California, Los Angeles, an M.S. in Applied Mathematics from Brown University, and a doctorate from the University of California, Los Angeles.
Dawn Owens
Director
Dawn Owens is president of TripleTree Holdings, with broad responsibility across TripleTree’s investment banking and TT Capital Partner’s private equity services. Dawn brings extensive healthcare experience to the firm, including a national reputation as a dynamic leader who has lead companies through various stages of growth, from turnaround to high growth. In her role, Dawn engages industry stakeholders, from innovative and earlier-stage companies to Fortune 200 leaders, to understand the market forces driving disruption and the potential for continued innovation in healthcare. Prior to joining the firm, Dawn served as CEO of OptumHealth, a multi-line UnitedHealth Group company. Under her leadership, OptumHealth became one of the nation’s largest and most respected health and well-being companies. Dawn’s prior roles include Chief Marketing Officer of Ingenix (now OptumInsight) and President of Uniprise (now a part of UnitedHealthcare). She started her healthcare career at Aetna Health Plans. Dawn earned a B.A. from Grove City College.
Advisory Board
Allan Ebbin, MD, MPH
Advisor
Rebecca Sutphen, MD, FACMGG
Chair
Dr. Sutphen is a board-certified clinical and molecular geneticist. She is Co-founder and Chief Medical Officer at InformedDNA. She also serves as Professor of Genetics at the University of South Florida Morsani College of Medicine. Dr. Sutphen is among the few individuals certified by the American Board of Medical Genetics in clinical genetics, molecular genetics and cytogenetics.
Dr. Dungan is a board-certified specialist in Reproductive Genetics. He is an Associate Professor of Clinical Genetics in the Department of Obstetrics and Gynecology at Northwestern University’s Feinberg School of Medicine.
Allan Ebbin, MD, MPH, is a clinical geneticist and executive physician. He has extensive experience in medical management, medical quality, and outcomes measurement. Dr. Ebbin’s specific areas of expertise include managed healthcare systems, quality assurance, quality improvement and risk management with special emphasis on quality clinical care, financial goals, and productivity.
Dr. Friedman is executive director of FORCE (Facing Our Risk of Cancer Empowered, Inc.), the leading national non-profit organization devoted to hereditary breast and ovarian cancer. The organization’s mission includes support, education, advocacy awareness, and research related to these cancers.
Dr. Ganz is a board certified medical oncologist with expertise in health policy and management as it relates to cancer. She is associate director for population science at the Jonsson Comprehensive Cancer Center, Los Angeles, and distinguished professor in the UCLA Schools of Medicine and Public Health. At the Jonsson Comprehensive Cancer Center, Dr. Ganz leads the scientific program focused on patients and survivors, as well as the cancer genetic counseling service. She served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. Dr. Ganz was elected to the Institute of Medicine in 2007, and received the American Cancer Society Medal of Honor in 2010. She currently serves as vice chair of the Institute of Medicine National Cancer Policy Forum.
Terhilda Garrido
Advisor
Terhilda Garrido is a leader in analytics, innovation and health IT, and retired from Kaiser
Permanente after 29 years of service. Most recently, she was vice president of health information technology transformation and analytics within the Quality and Care Delivery Excellence organization. Currently, Ms. Garrido is an executive in residence at GE Ventures, reviewing HIT startups for investment.
Dr. Krischer is distinguished professor at University of South Florida Morsani College of Medicine, where he is also director of the Health Informatics Institute and the Diabetes Center. The USF Diabetes Center is internationally recognized for its research on diabetes and related autoimmune diseases.
Dr. Iftikhar Kullo is a clinician investigator in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota. He heads the Atherosclerosis and Lipid Genomics Laboratory, chairs the Cardiovascular Genomics Task Force, and directs the Early Atherosclerosis and Familial Hypercholesterolemia Clinics at Mayo Clinic. Dr. Kullo is also the co-principal investigator of the Mayo electronic MEdical Records and GEnomics (eMERGE) grant, and a member of ClinGen’s work group on polygenic risk scores and LDLR annotation. He works closely with patient advocacy group, the FH Foundation.
Dr. Anil Malhotra is the director of psychiatry research at the Zucker Hillside Hospital in Glen Oaks, NY; professor at the Department of Molecular Medicine and the Department of Psychiatry at Hofstra Northwell School of Medicine in Hempstead, NY; and, a professor at the Feinstein Institute for Medical Research in Manhasset, NY.
Chad Pomeroy
Advisor
Chad Pomeroy is chief solutions officer for Positive Development Inc. He previously led Evolent Health’s information technology group, consumer innovation for WellPoint, and was chief technology officer for Lumenos, one of the pioneers of consumer-driven health plans.
Vicki Shepard, JD
Advisor
Vicki Shepard is a 30-year veteran of law enforcement, focusing on healthcare fraud and abuse. As former deputy inspector general for the U.S. Department of Health and Human Services, she was known for her keen determination to detect and prevent fraud among more than 300 HHS programs. Ms. Shepard received her JD from the College of Law at the University of Denver.
Myra Wick, MD, PhD
Advisor
Dr. Myra Wick is a Mayo Clinic specialist in obstetrics, gynecology, and medical genetics. She is an assistant professor of Medical Genetics, Obstetrics, and Gynecology, and serves as the medical co-editor of the Mayo Clinic’s Guide to a Healthy Pregnancy.
Sign up to receive periodic news, resources, and updates.
